JA PCM is opening its doors to private sector engagement. For the implementation of the pilot activities, the JA PCM seeks collaboration with the private sector to scale up and align with the JA PCM's ambitions. The scope of opportunities includes topics such as Next Generation Sequencing (NGS) tests, medicinal products, including drugs, digital health tools, as well as private sector perspectives into workshop or survey activities.
This collaborative approach with the private sector will test and support a more robust rollout of pilot activities and enable the pilots to achieve their full pan-European potential and ultimately move PCM from fragmented implementation to systemic integration across Europe. It is in that respect that the JA PCM has developed this document to reach out to the private sector for opportunities to engage in pilot activities and to initiate discussions on the development of a suitable collaborative framework that will go beyond the JA PCM project.
This document serves a dual purpose:
- Outline the scope of collaboration, including the overall strategy around this collaboration, the value proposition, the modalities of collaboration and the foundation for a sustainable and evolving public-private collaboration beyond the lifetime of the Joint Action.
- Present the JA PCM pilot activities, emphasizing the immediate private sector opportunities.
📄Learn more by reading the full memorandum below.